The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $2,706.51 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of M-M-R II vaccine vials and has a period of performance through March 22, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $30,556.20 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of M-M-R II vaccine vials and has a period of performance through April 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle to provide a comprehensive range of pharmaceutical products...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $2,049.52 to Amerisourcebergen Drug Corp's Corporate Office division for the supply of M-M-R II vaccine vials. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $8,798.16 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the provision of M-M-R II vaccine vials, with a completion date of February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) awarded by DLA with a...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,537.14 firm fixed price delivery order contract to provide M-M-R II vaccine vials. The contract has a completion date of February 28, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. This award is part of Amerisourcebergen's indefinite...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $15,347.99 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the provision of M-M-R II vaccine vials and has a completion date of February 27, 2024. Amerisourcebergen Drug Corp serves as a prime contractor to DLA Troop Support Medical, providing a wide range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,049.52 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of M-M-R II vaccine vials and does not have a set-aside designation. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to...
The U.S. Defense Logistics Agency (DLA) awarded a $3,332.32 firm fixed-price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of 4,565,372,780 M-M-R II vaccine vials. This award is not set aside and has an ultimate completion date of August 8, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several indefinite delivery contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of M-M-R II vaccine vials. The delivery order has a potential value of $4,326.46 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors noted. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC)...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,170.22 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide M-M-R II vaccine vials. This order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to...